DESCRIPTION
Do excipient unknowns derail your drug development project? What you don’t know about your excipients might surprise you, and could impact your product. The rational incorporation of excipients into quality-by-design (QbD) can inject robustness into your products and protect them against potential failures.
This webinar will review the impact of the new IPEC QbD guide on product development and life-cycle management.
Discussion will cover:
LEARNING OBJECTIVES
Attendees will be able to:
DATE AND TIME
Wednesday 13 January 2021 - 10:00 EST / 15:00 GMT / 16:00 CET
REGISTRATION FEES
IPEC Federation Member companies: FREE (applicable to IPEC Europe Members)
IPEC Federation Non Member companies: $ 59
PRESENTERS
Dave R. Schoneker, Consultant
Chris Moreton, Ph.D., Consultant, FinnBrit Consulting
Brian AC Carlin, Ph.D., Director QbD/Regulatory, DFE Pharma